NeuroPace, Inc.
Status: Publicly traded
Direct answer
NeuroPace, Inc. is publicly traded on NASDAQ under the ticker NPCE.
NeuroPace, Inc. is a U.S.-based medical technology firm. It specializes in the creation and distribution of the RNS system, an advanced brain-responsive neuromodulation device designed to manage medically intractable focal epilepsy. This innovative system delivers tailored, real-time therapy directly to the source of seizures. Furthermore, the RNS system continuously records brain activity, providing medical...
Can you invest in NeuroPace, Inc.?
Yes. NeuroPace, Inc. trades publicly on NASDAQ as NPCE.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for NeuroPace, Inc.
Detailed equity research is provided by MarketSnap.